ATE105480T1 - Thrombin bindende substanz und verfahren zu ihrer herstellung. - Google Patents

Thrombin bindende substanz und verfahren zu ihrer herstellung.

Info

Publication number
ATE105480T1
ATE105480T1 AT8989115272T AT89115272T ATE105480T1 AT E105480 T1 ATE105480 T1 AT E105480T1 AT 8989115272 T AT8989115272 T AT 8989115272T AT 89115272 T AT89115272 T AT 89115272T AT E105480 T1 ATE105480 T1 AT E105480T1
Authority
AT
Austria
Prior art keywords
thrombin
binding substance
binding
conditions
production
Prior art date
Application number
AT8989115272T
Other languages
English (en)
Inventor
Nobuo Aoki
Shigeru Kimura
Masami Shiratsuchi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE105480T1 publication Critical patent/ATE105480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT8989115272T 1988-08-29 1989-08-18 Thrombin bindende substanz und verfahren zu ihrer herstellung. ATE105480T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP21413988 1988-08-29
JP11647189 1989-05-10
JP1202027A JPH0720997B2 (ja) 1988-08-29 1989-08-03 新規なトロンビン結合性物質及びその製法
EP89115272A EP0356836B1 (de) 1988-08-29 1989-08-18 Thrombin bindende Substanz und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE105480T1 true ATE105480T1 (de) 1994-05-15

Family

ID=27313158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT8989115272T ATE105480T1 (de) 1988-08-29 1989-08-18 Thrombin bindende substanz und verfahren zu ihrer herstellung.

Country Status (7)

Country Link
US (1) US5043425A (de)
EP (1) EP0356836B1 (de)
JP (1) JPH0720997B2 (de)
KR (2) KR900003207A (de)
AT (1) ATE105480T1 (de)
DE (1) DE68915226T2 (de)
ES (1) ES2056164T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
JPH03259084A (ja) * 1990-03-06 1991-11-19 Kowa Co トロンビン結合性物質の製造法
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
US5716795A (en) * 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
US20050089543A1 (en) * 2001-02-01 2005-04-28 Weiser Mark J. Animal scent based repellent and attractant compositions
JP4340540B2 (ja) * 2002-01-18 2009-10-07 旭化成ファーマ株式会社 可溶性トロンボモジュリン高濃度含有製剤
MX2009003384A (es) * 2006-10-06 2009-04-08 Asahi Kasei Pharma Corp Agente terapeutico y/o de mejoramiento para la coagulacion intravascular diseminada.
CA2681294C (en) 2007-03-23 2014-05-06 Asahi Kasei Pharma Corporation Method for producing high-purity soluble thrombomodulin
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および／または治療剤
NZ602852A (en) 2010-04-30 2014-03-28 Asahi Kasei Pharma Corp Highly-purified soluble thrombomodulin and method for producing same
PT2781221T (pt) 2011-11-15 2020-06-01 Asahi Kasei Pharma Corp Medicamento para tratamento e/ou melhoria de sepsia
DK2857037T3 (da) 2012-05-31 2019-07-22 Univ Kinki Middel til forebyggelse og/eller behandling af perifere neuropatiske smerter forårsaget af anticancerlægemiddel
CA3112679A1 (en) 2018-09-28 2020-04-02 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent
BR112021007460A2 (pt) 2018-10-22 2021-11-03 Asahi Kasei Pharma Corp Medicamento para tratamento terapêutico e/ou melhora de um paciente com sepse

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60199819A (ja) * 1984-03-23 1985-10-09 Kowa Co トロンビン結合性物質およびその製法
WO1987000050A1 (fr) * 1985-06-28 1987-01-15 Asahi Kasei Kogyo Kabushiki Kaisha Nouvelle substance physiologiquement active limitant la coagulation du sang
JPH0689014B2 (ja) * 1986-01-21 1994-11-09 興和株式会社 トロンビン結合性物質およびその製法
DE3750664T2 (de) * 1986-07-15 1995-06-22 Kowa Co Throminbindende Substanz und Verfahren zu ihrer Herstellung.
JP2738428B2 (ja) * 1987-01-08 1998-04-08 旭化成工業株式会社 トロンビンによるプロテインｃの活性化を促進する作用を有するペプチド
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof

Also Published As

Publication number Publication date
DE68915226D1 (de) 1994-06-16
EP0356836A3 (en) 1990-03-28
DE68915226T2 (de) 1995-01-05
KR900003207A (ko) 1990-03-26
KR940027658A (ko) 1994-12-10
JPH0720997B2 (ja) 1995-03-08
JPH0386900A (ja) 1991-04-11
US5043425A (en) 1991-08-27
EP0356836A2 (de) 1990-03-07
EP0356836B1 (de) 1994-05-11
ES2056164T3 (es) 1994-10-01

Similar Documents

Publication Publication Date Title
ATE59962T1 (de) Thrombin bindender stoff und verfahren zu seiner herstellung.
DE68915226D1 (de) Thrombin bindende Substanz und Verfahren zu ihrer Herstellung.
DE3684078D1 (de) Reinigung und aktivierung von proteinen aus unloeslichen einschlusskoerpern.
FI102836B1 (fi) Menetelmä glykosaminoglykaanilla muunnetun proteiinin valmistamiseksi
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
DE3778857D1 (de) Katalytische produktion von optisch aktiven carbonsaeuren.
DE3688760D1 (de) Expression von faktor-vii-aktivitaet in saeugetierzellen.
ATE108206T1 (de) Gewebe-plasminogenaktivator.
WO1998017319A3 (en) Platelet substitutes and conjugation methods suitable for their preparation
ATE114319T1 (de) Produktion von proteinen in aktiven formen.
ATE345384T1 (de) Nitrilase und dafür kodierendes polynukleotid
ATE42178T1 (de) Zusammengesetztes fleischprodukt und verfahren zu dessen herstellung.
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
NL960017I2 (nl) Expressie van Factor VIII-activiteit in zoogdiercellen.
DE68918279D1 (de) Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.
ATE113062T1 (de) Throminbindende substanz und verfahren zu ihrer herstellung.
ATE270327T1 (de) Verfahren zur präparation von humanem aktiviertem protein c
DE59308942D1 (de) Verfahren zur Bestimmung von Fibrinogen
ATE15489T1 (de) Die blutkoagulation aktivierendes produkt und verfahren zu dessen herstellung.
ES2033295T3 (es) Un metodo para preparar un activador de plasminogeno.
ATE108833T1 (de) Antikörper gegen fibrin, immunogene peptide für die herstellung dieser antikörper, verfahren zur bestimmung von fibrin und pharmazeutische zubereitungen auf der basis dieser antikörper.
DE58907892D1 (de) Verfahren zur Herstellung von optisch aktiven alpha-Aminoacetalen.
DE68910033D1 (de) Katalytisches Verfahren zur Herstellung von optisch-aktiven Alpha-Hydroxycarboxylaten.
HUT60133A (en) Process for producing protein-based pharmaceutical composition having t-pa-activity and suitable for treating blood clots
NZ240782A (en) Thrombin binding protein, its production by genetic engineering, and pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee